Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT03211520
Eligibility Criteria:
Inclusion Criteria:
* \- Age (≥9years old)
* Newly diagnosed with a malignancy that is anticipated to receive high dose anthracyclines as part of their chemotherapy (such as but not limited to solid tumors, high risk Acute Lymphocytic Leukemia, Acute myelogenous Leukemia and lymphomas)
* Parental/caregiver consent and subject assent to enrollment
Exclusion Criteria:
* \- Contraindications to CMRI.\*
* Patients requiring sedation for the CMRI procedure
* Pregnancy tests are done routinely prior to chemotherapy, if test is positive the patient will be excluded
* Subject is too large to be safely accommodated by MRI
* Serum creatinine higher than the guidelines for adequate renal function
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
9 Years
Maximum Age:
18 Years
Study:
NCT03211520
Study Brief:
Protocol Section:
NCT03211520